We recently developed a method of proton magnetic resonance spectroscopy (1H-MRS) to measure the 1H-MR spectra of peripheral blood lymphocytes (PBL) using only 10(7) cells. We investigated the clinical feasibility of this method for evaluating disease activities in sarcoidosis and interstitial pneumonitis. PBL was separated from 10 ml of venous blood by differential centrifugation with Ficoll-Conray. Using a 90 MHz MR spectrometer (EX90, JEOL), the spectrum was obtained with 4000 times accumulation of 1H signals by single 70 degree pulses at 37 degrees C under spinning. Water signal was suppressed with the homo-gated decoupling sequence. The spectra were analyzed with Gaussian curve fitting. The spectra of patients with active disease showed significant increases in peak heights for (CH2)n and CH3 peaks compared with the control. The peak heights decreased after improvement of disease states. The changes in 1H-MR spectra suggested activation of PBL in patients with sarcoidosis and interstitial pneumonitis, since similar changes have been shown for cells activated with mitogens. Our preliminary results indicate that 1H-MRS may be useful to evaluate activation of PBL in sarcoidosis and interstitial pneumonitis.
[1]
N. Hunt,et al.
Development of the “activated” high resolution 1H MR spectrum in murine T cells and B cells occurs in G1 phase of the cell cycle
,
1990,
Magnetic resonance in medicine.
[2]
W. Mackinnon,et al.
NMR methods for characterizing the state of the surfaces of complex mammalian cells.
,
1984,
Journal of biochemical and biophysical methods.
[3]
R M Fox,et al.
Characterization of transformed cells and tumors by proton nuclear magnetic resonance spectroscopy.
,
1982,
Cancer research.
[4]
C. Mountford,et al.
High-resolution proton nuclear magnetic resonance: application to the study of leukaemic lymphocytes.
,
1980,
British Journal of Cancer.
[5]
C. Mountford,et al.
Proton magnetic resonance spectroscopy and tumour detection.
,
1987,
Cancer surveys.